OBJECTIVES: I. Compare the resting energy expenditure using respiratory calorimetry in
infants and children with moderate to severe cystic fibrosis versus age matched healthy
II. Determine the total energy expenditure and energy spent on physical activity using the
doubly labeled water method in these patient populations.
PROTOCOL OUTLINE: Patients and healthy controls receive an oral dose of doubly labeled water
following initial urine collection on day 1. Patients undergo additional urine collection
at 4-6 hours following doubly labeled water consumption and then daily for 7 days.
Additionally, at the beginning of the study, patients and healthy controls undergo
respiratory calorimetry over approximately 45 minutes at rest, starting approximately 2-3
hours after the last meal consumption and last use of aerosol bronchodilators (if required).
PROTOCOL ENTRY CRITERIA:
- Diagnosis of cystic fibrosis (CF) by two positive sweat tests No exacerbations of
present condition within past 2 months FEV1 less than 50% of predicted No other
uncorrected lung disease No requirement for supplemental oxygen
- Healthy (control group) Age matched to CF patients No preexisting lung disease
Clinically well No hospitalizations within past 6 months
- Concurrent pancreatic enzyme supplementation for CF required Clinically stable on
current medications (CF patients)
- Age: Birth to 12 months 6 to 10 years
- Cardiovascular: No major cardiovascular problems (CF patients) No preexisting heart
disease (control group)
- Pulmonary: See Disease Characteristics
- Other: No chromosomal abnormalities (CF patients) No acute infection (CF patients) No
diabetes mellitus (both groups)